Results 71 to 80 of about 5,852 (193)
Pseudomyxoma Peritonei: Radiological Aspect
Pseudomyxoma peritonei is one of the complications of mucin secreting tumours arising from appendix or ovary. Malignancy of biliary tree, urachus and colon may also have similar presentation.
Ashish Garg+4 more
doaj +1 more source
PSEUDOMYXOMA PERITONEI A RARE CASE [PDF]
This is a case report of a 55- year old male patient who presented with features of intestinal obstruction. The obstruction which was relieved surgically by removal of fibrous adhesions was found to be the result of Pseudomyxoma peritonei however, at ...
Idris, Mustafa+2 more
core +1 more source
Prognostic factors influencing infectious complications after cytoreductive surgery and HIPEC. Results from a tertiary referral center [PDF]
Background. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application.
Carbonari, Ludovica+8 more
core +1 more source
Review of 2022 PSOGI/RENAPE Consensus on HIPEC
ABSTRACT The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range
Shigeki Kusamura+25 more
wiley +1 more source
PSEUDOMYXOMA PERITONEI – AN ENDOSCOPIC IMAGE
-
Shafqat Mehmood+3 more
doaj +1 more source
Imaging of Peritoneal Surface Malignancies
ABSTRACT Management of peritoneal surface malignancies is currently entrusted to a multimodality approach. Computed tomography (CT) scan remains the first imaging method despite the limitations in identifying small implants in critical regions. Magnetic resonance imaging is usually recommended for its performance in small implants, mesentery, and small
Damiano Caruso+9 more
wiley +1 more source
ABSTRACT The main aim of this review is to analyze postoperative complications after cytoreductive surgery and intraperitoneal chemotherapy. Although the literature in this field is ever growing, reporting on complication is not a given. Nevertheless, some main risk factors such as prior surgery, high tumor burden and the center's expertize have an ...
Miguel E. Alberto V.+5 more
wiley +1 more source
Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion
Introduction: The rationale for intraperitoneal (IP) drug delivery for patients with peritoneal metastases (PM) is based on the pharmacokinetic advantage resulting from the peritoneal-plasma barrier, and on the potential to adequately treat small, poorly
Braet, Helena+4 more
core +1 more source
Interstitial pneumonitis following intrapleural chemotherapy [PDF]
Background Mucinous neoplasms within the abdomen may disseminate by direct extension through the diaphragm to involve the pleural space. Treatment of this condition is by parietal and visceral pleurectomy followed by hyperthermic intrapleural ...
Humphries, Gary N+3 more
core +3 more sources
Multi‐Society Guideline on Cytoreductive Surgery and HIPEC: Methodology and Overview of the Results
ABSTRACT To provide evidence‐based guidelines about Peritoneal Surface Malignancy (PSM) treatment for the Peritoneal Surfaces Oncology Group International. The GRADE ADOLOPMENT method was used to adapt recommendations from the Italian Medical Oncology Association Guideline on PSM.
Michela Cinquini+5 more
wiley +1 more source